{
    "pmcid": "PMC4840965",
    "content": {
        "title": "Recurrences in stage II rectal carcinoma after curative resection\n                    alone: from the viewpoint of angiogenesis",
        "abstract": "Angiogenesis plays a pivotal role in malignant tumor progression. The count\n                        of blood microvessels of the tumor has been recognized as an indicator of\n                        malignant potential of the tumors and provides the ability to predict tumors\n                        recurrence. The role endoglin in the Dukes B rectal cancer is still\n                        unexplored. The aims of this study were to examine immunohistochemical\n                        expression of endoglin in resected rectal cancer and investigate the\n                        relationship of tumor recurrence and other clinicopathological variables to\n                        the endoglin-assessed microvessel density of the tumor tissue and distal\n                        resection margins.\nThe study included 95 primary rectal adenocarcinomas, corresponding to 95\n                        distal and 95 proximal resection margin specimens from surgical resection\n                        samples. Tumor specimens were paraffin embedded, and immunohistochemical\n                        staining for the CD105 endothelial antigen was performed to count CD105-MVD.\n                        For exact measurement of the CD105-MVD used, a computer-integrated system\n                        Alphelys Spot Browser 2 was used.\nThe MVD was significantly higher in the tumor samples compared with the\n                        distal resection margins (\nCD105-assessed MVD could help to identify patients with more aggressive\n                        disease and increased risk of developing tumor recurrence after surgical\n                        treatment in stage II rectal cancer (RC).",
        "keywords": [
            "Rectal cancer",
            "Angiogenesis",
            "Microvessel density",
            "Endoglin",
            "Recurrence"
        ],
        "tables": [
            {
                "table_id": "Tab1",
                "body": "<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n",
                "caption": "<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n",
                "foots": [],
                "paragraphs": [
                    {
                        "text": "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                        "citations": [
                            "<ref id=\"CR9\">\n<label>9.</label>\n<mixed-citation publication-type=\"other\">Edge SB, Byrd DR, Compton CC, Fritz AG,\nGreen FL, Trotti A, Eds. AJCC: colon and rectum in AJCC Cancer Staging Manual.\n7th edition. New York, NY USA: Springer; 2010. p. 143\u201364.</mixed-citation>\n</ref>\n",
                            "<ref id=\"CR10\">\n<label>10.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Barresi</surname>\n<given-names>V</given-names>\n</name>\n<name>\n<surname>Bonetti</surname>\n<given-names>LR</given-names>\n</name>\n<name>\n<surname>Ieni</surname>\n<given-names>A</given-names>\n</name>\n<name>\n<surname>Branca</surname>\n<given-names>G</given-names>\n</name>\n<name>\n<surname>Baron</surname>\n<given-names>L</given-names>\n</name>\n<name>\n<surname>Tuccari</surname>\n<given-names>G</given-names>\n</name>\n</person-group>\n<article-title>Histologic grading based on counting poorly differentiated\nclusters in preoperative biopsy predict nodal involvement and pTNM stage in\ncolorectal cancer patients</article-title>\n<source>Hum Pathol</source>\n<year>2014</year>\n<volume>45</volume>\n<fpage>268</fpage>\n<lpage>75</lpage>\n<pub-id pub-id-type=\"doi\">10.1016/j.humpath.2013.07.046</pub-id>\n<pub-id pub-id-type=\"pmid\">24289972</pub-id>\n</element-citation>\n</ref>\n"
                        ]
                    },
                    {
                        "text": "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                        "citations": []
                    }
                ],
                "cells": [
                    {
                        "content": "Total number",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "95",
                        "cited_in": [
                            "<p>The study included 95 primary rectal adenocarcinomas, corresponding to 95\ndistal and 95 proximal resection margin specimens from surgical resection\nsamples. Tumor specimens were paraffin embedded, and immunohistochemical\nstaining for the CD105 endothelial antigen was performed to count CD105-MVD.\nFor exact measurement of the CD105-MVD used, a computer-integrated system\nAlphelys Spot Browser 2 was used.</p>\n",
                            "<p>We studied 95 cases of primary rectal adenocarcinomas in stage II (T3\u2013T4,\nN0, M0) treated by complete surgical resection (R0) in a 5-year period at Clinic\nfor Surgery, Clinical Hospital Center Rijeka, Croatia, from January 2002 to\nDecember 2006. The study included 95 primary rectal adenocarcinomas, 95 surgical\ndistal resection margin specimens, and 95 surgical proximal resection margin\nspecimens from surgical resection samples. The distal resection margin (DRM) and\nproximal resection margin (PRM) corresponding to the primary tumor from the same\npatients was taken from the margin of near and distant surgical resection.\nTissue samples included in this study were retrieved from the archives of the\nInstitute of Pathology School of Medicine of Rijeka, Croatia. The exclusion\ncriteria were a synchronous tumor or tumors in another localization in\nanamnesis, emergency surgery, preoperative radiotherapy or chemotherapy,\nperforation of bowel, and incomplete clinical data. The study was approved by\nthe University of Rijeka Ethics Committee and patients signed informed consent.</p>\n",
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>Statistical analysis was performed using MedCalc version 14.8.1 (MedCalc Software\nbvba, Mariakerke, Belgium). Descriptive statistics and 95\u00a0% confidence\nintervals were calculated to describe data. The distribution of data was tested\nfor normality using the Smirnov-Kolmogorov test. The Mann-Whitney <italic>U</italic>\ntest and Kruskal-Wallis tests were used to compare MVD among the\nclinicopathological variables. Spearman\u2019s rho correlation was used to\ntest the correlation between the immunohistochemical findings and tumor\nrecurrence. The receiver operating characteristic (ROC) curve approach was used\nto determine best-fitting cut-off for the MVD in terms of the tumor recurrence\nanalysis [<xref ref-type=\"bibr\" rid=\"CR12\">12</xref>]. Tumor recurrence analysis\nwas estimated by the Kaplan-Meier method and compared by the log rank test.\nPrognostic factors of tumor recurrence were identified by the use of the Cox\nproportional hazard regression. Differences at <italic>p</italic>\u2009&lt;\u20090.05\nwere considered significant.</p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n"
                        ]
                    },
                    {
                        "content": "Age, median 69\u00a0years",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "\u226469",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "49",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n"
                        ]
                    },
                    {
                        "content": ">69",
                        "cited_in": []
                    },
                    {
                        "content": "46",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "Gender",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Male",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "61",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n"
                        ]
                    },
                    {
                        "content": "Female",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "34",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n",
                            "<p>In the present study, we found a significant inverse correlation between the\nCD105-MVD in the distal resection margins and the length of DRM that were closest to\nthe RC. This analysis suggested an active reaction of the adjacent mucosa related to\nthe presence of the tumor, but a more passive reaction induced by the factors\nreleased from the tumor [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. Also, our\nresult shows a significant correlation between the CD105-MVD and tumor recurrence:\nsignificantly higher rates of tumor recurrence were found in patients with higher\nCD105-MVD in distal resection margins than cut-off value obtained by ROC analysis.\nRegarding the pattern of recurrence after surgery alone, we revealed that lower\nCD105-MVD in tumors and higher CD105-MVD in distal resection margins significantly\ncorrelated with tumor recurrence, suggesting that CD105 may be involved in\ndeveloping tumor recurrence in rectal cancer. However, the results of different\nstudies are linking the lower tumor vascularity with poor outcomes and in various\nother solid tumors [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Only recently\nacquired knowledge has led to the conclusions that the local tissue microenvironment\ncontributes significantly to tumor progression.</p>\n",
                            "<p>We hypothesize that a crosstalk exists between rectal tumor cells and adjacent mucosa\nof distal margin. Tumor secretes cytokines and other signaling proteins which induce\nangiogenesis in the adjacent mucosa of distal margin [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. TGF-\u03b21, a multifunctional cytokine, has a complex\nrole in angiogenesis. It is expressed in number of cell types, including endothelial\ncells, depending on the concentration, is both pro angiogenic and antiangiogenic [<xref ref-type=\"bibr\" rid=\"CR36\">36</xref>]. One molecule that may orchestrate this\nbalance is endoglin [<xref ref-type=\"bibr\" rid=\"CR37\">37</xref>]. Endoglin is an\nauxiliary membrane receptor for transforming growth factor beta (TGF-\u03b2) that\nmodulates TGF-\u03b2 signaling [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>].\nRecently, endoglin has been identified as a key regulator of tumor cells\nproliferation, migration, and invasion [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>, <xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Craft et al. showed that endoglin\nexpression was lost during prostate cancer cell progression, and that led to\nincreased cell invasion and migration [<xref ref-type=\"bibr\" rid=\"CR38\">38</xref>].\nIt has been suggested that endoglin deficiency results in angiogenic adaptation,\nweakens the endothelial barrier, and increased metastatic spread and may be\nassociated with cancer progression [<xref ref-type=\"bibr\" rid=\"CR39\">39</xref>].</p>\n",
                            "<p>hematopoietic progenitor cell antigen CD34</p>\n"
                        ]
                    },
                    {
                        "content": "Type of surgery",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "Low anterior resection",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "76",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n"
                        ]
                    },
                    {
                        "content": "Abdominoperineal resection",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "19",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>Recurrence rates in our cohort stage II RC patients were analyzed according to age,\ngender, surgery, tumor location, grade of differentiation, histology, depth of tumor\ninvasion, and tumor size (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>).\nBy univariate analysis, only the type of surgical resection was found to be\nsignificant prognostic factors for tumor recurrence. Patients treated with a primary\nAPR had a higher rate of tumor recurrence than those who underwent a LAR, which is\nin accordance with the results of most of the authors [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>]. Previous studies have demonstrated an LAR to APR ratio\n3:1 or 4:1 which is consistent with our results [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>\n, <xref ref-type=\"bibr\" rid=\"CR20\">20</xref>]. However, most studies were too small\nto adequately evaluate the relationship between the type surgery and tumor\nrecurrence (TR). The key to successful surgery is complete excision of the tumor\nwith sufficient margin of normal tissue. TR may also sometimes occur even in the\nabsence of an involved CRM possibly owing to lymphatic spread from the distal rectum\nto lymph nodes in the pelvic side wall [<xref ref-type=\"bibr\" rid=\"CR21\">21</xref>].\nIn low rectal cancer, total mesorectal excision (TME) surgery may be insufficient to\nobtain the desired CRM because of lack of mesorectum at the level of the pelvic\nfloor [<xref ref-type=\"bibr\" rid=\"CR22\">22</xref>]. APR surgery frequently results\nin perineal and presacral TR [<xref ref-type=\"bibr\" rid=\"CR23\">23</xref>]. The\nchoice of surgical resection is limited and influenced by tumor staging, tumor\nlocation, and intrapelvic tumor invasion at the time of the diagnosis [<xref ref-type=\"bibr\" rid=\"CR24\">24</xref>].</p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n"
                        ]
                    },
                    {
                        "content": "Tumor location",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Upper rectum",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "23",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n",
                            "<p>Recurrence rates in our cohort stage II RC patients were analyzed according to age,\ngender, surgery, tumor location, grade of differentiation, histology, depth of tumor\ninvasion, and tumor size (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>).\nBy univariate analysis, only the type of surgical resection was found to be\nsignificant prognostic factors for tumor recurrence. Patients treated with a primary\nAPR had a higher rate of tumor recurrence than those who underwent a LAR, which is\nin accordance with the results of most of the authors [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>]. Previous studies have demonstrated an LAR to APR ratio\n3:1 or 4:1 which is consistent with our results [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>\n, <xref ref-type=\"bibr\" rid=\"CR20\">20</xref>]. However, most studies were too small\nto adequately evaluate the relationship between the type surgery and tumor\nrecurrence (TR). The key to successful surgery is complete excision of the tumor\nwith sufficient margin of normal tissue. TR may also sometimes occur even in the\nabsence of an involved CRM possibly owing to lymphatic spread from the distal rectum\nto lymph nodes in the pelvic side wall [<xref ref-type=\"bibr\" rid=\"CR21\">21</xref>].\nIn low rectal cancer, total mesorectal excision (TME) surgery may be insufficient to\nobtain the desired CRM because of lack of mesorectum at the level of the pelvic\nfloor [<xref ref-type=\"bibr\" rid=\"CR22\">22</xref>]. APR surgery frequently results\nin perineal and presacral TR [<xref ref-type=\"bibr\" rid=\"CR23\">23</xref>]. The\nchoice of surgical resection is limited and influenced by tumor staging, tumor\nlocation, and intrapelvic tumor invasion at the time of the diagnosis [<xref ref-type=\"bibr\" rid=\"CR24\">24</xref>].</p>\n"
                        ]
                    },
                    {
                        "content": "Middle rectum",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "52",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Low rectum",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "20",
                        "cited_in": [
                            "<p>We studied 95 cases of primary rectal adenocarcinomas in stage II (T3\u2013T4,\nN0, M0) treated by complete surgical resection (R0) in a 5-year period at Clinic\nfor Surgery, Clinical Hospital Center Rijeka, Croatia, from January 2002 to\nDecember 2006. The study included 95 primary rectal adenocarcinomas, 95 surgical\ndistal resection margin specimens, and 95 surgical proximal resection margin\nspecimens from surgical resection samples. The distal resection margin (DRM) and\nproximal resection margin (PRM) corresponding to the primary tumor from the same\npatients was taken from the margin of near and distant surgical resection.\nTissue samples included in this study were retrieved from the archives of the\nInstitute of Pathology School of Medicine of Rijeka, Croatia. The exclusion\ncriteria were a synchronous tumor or tumors in another localization in\nanamnesis, emergency surgery, preoperative radiotherapy or chemotherapy,\nperforation of bowel, and incomplete clinical data. The study was approved by\nthe University of Rijeka Ethics Committee and patients signed informed consent.</p>\n",
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n",
                            "<p>Recurrence rates in our cohort stage II RC patients were analyzed according to age,\ngender, surgery, tumor location, grade of differentiation, histology, depth of tumor\ninvasion, and tumor size (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>).\nBy univariate analysis, only the type of surgical resection was found to be\nsignificant prognostic factors for tumor recurrence. Patients treated with a primary\nAPR had a higher rate of tumor recurrence than those who underwent a LAR, which is\nin accordance with the results of most of the authors [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>]. Previous studies have demonstrated an LAR to APR ratio\n3:1 or 4:1 which is consistent with our results [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>\n, <xref ref-type=\"bibr\" rid=\"CR20\">20</xref>]. However, most studies were too small\nto adequately evaluate the relationship between the type surgery and tumor\nrecurrence (TR). The key to successful surgery is complete excision of the tumor\nwith sufficient margin of normal tissue. TR may also sometimes occur even in the\nabsence of an involved CRM possibly owing to lymphatic spread from the distal rectum\nto lymph nodes in the pelvic side wall [<xref ref-type=\"bibr\" rid=\"CR21\">21</xref>].\nIn low rectal cancer, total mesorectal excision (TME) surgery may be insufficient to\nobtain the desired CRM because of lack of mesorectum at the level of the pelvic\nfloor [<xref ref-type=\"bibr\" rid=\"CR22\">22</xref>]. APR surgery frequently results\nin perineal and presacral TR [<xref ref-type=\"bibr\" rid=\"CR23\">23</xref>]. The\nchoice of surgical resection is limited and influenced by tumor staging, tumor\nlocation, and intrapelvic tumor invasion at the time of the diagnosis [<xref ref-type=\"bibr\" rid=\"CR24\">24</xref>].</p>\n"
                        ]
                    },
                    {
                        "content": "Grade of differentiation",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "G1",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "55",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "G2",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "34",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n",
                            "<p>In the present study, we found a significant inverse correlation between the\nCD105-MVD in the distal resection margins and the length of DRM that were closest to\nthe RC. This analysis suggested an active reaction of the adjacent mucosa related to\nthe presence of the tumor, but a more passive reaction induced by the factors\nreleased from the tumor [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. Also, our\nresult shows a significant correlation between the CD105-MVD and tumor recurrence:\nsignificantly higher rates of tumor recurrence were found in patients with higher\nCD105-MVD in distal resection margins than cut-off value obtained by ROC analysis.\nRegarding the pattern of recurrence after surgery alone, we revealed that lower\nCD105-MVD in tumors and higher CD105-MVD in distal resection margins significantly\ncorrelated with tumor recurrence, suggesting that CD105 may be involved in\ndeveloping tumor recurrence in rectal cancer. However, the results of different\nstudies are linking the lower tumor vascularity with poor outcomes and in various\nother solid tumors [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Only recently\nacquired knowledge has led to the conclusions that the local tissue microenvironment\ncontributes significantly to tumor progression.</p>\n",
                            "<p>We hypothesize that a crosstalk exists between rectal tumor cells and adjacent mucosa\nof distal margin. Tumor secretes cytokines and other signaling proteins which induce\nangiogenesis in the adjacent mucosa of distal margin [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. TGF-\u03b21, a multifunctional cytokine, has a complex\nrole in angiogenesis. It is expressed in number of cell types, including endothelial\ncells, depending on the concentration, is both pro angiogenic and antiangiogenic [<xref ref-type=\"bibr\" rid=\"CR36\">36</xref>]. One molecule that may orchestrate this\nbalance is endoglin [<xref ref-type=\"bibr\" rid=\"CR37\">37</xref>]. Endoglin is an\nauxiliary membrane receptor for transforming growth factor beta (TGF-\u03b2) that\nmodulates TGF-\u03b2 signaling [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>].\nRecently, endoglin has been identified as a key regulator of tumor cells\nproliferation, migration, and invasion [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>, <xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Craft et al. showed that endoglin\nexpression was lost during prostate cancer cell progression, and that led to\nincreased cell invasion and migration [<xref ref-type=\"bibr\" rid=\"CR38\">38</xref>].\nIt has been suggested that endoglin deficiency results in angiogenic adaptation,\nweakens the endothelial barrier, and increased metastatic spread and may be\nassociated with cancer progression [<xref ref-type=\"bibr\" rid=\"CR39\">39</xref>].</p>\n",
                            "<p>hematopoietic progenitor cell antigen CD34</p>\n"
                        ]
                    },
                    {
                        "content": "G3",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "6",
                        "cited_in": [
                            "<p>The MVD was significantly higher in the tumor samples compared with the\ndistal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001).\nThere was no significant difference in the MVD between distal and proximal\nresection margins (<italic>p</italic>\u2009=\u20090.147). The type of\nsurgical resection was a significant factor for determining the recurrence\nof tumors (<italic>p</italic>\u2009=\u20090.0104). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade\nof differentiation, histological tumor type, and the size and depth of tumor\ninvasion on the recurrence of the tumor. The recurrence rate was\nsignificantly higher in the low CD105-MVD group of patients than in the high\nCD105-MVD group of patients (log rank test, <italic>p</italic>\u2009=\u20090.0406).\nResult of the multivariate analysis showed that the type of surgery (<italic>\np</italic>\u2009=\u20090.0086), MVD tumors (<italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (<italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for the recurrent tumors.</p>\n",
                            "<p>Tumor growth and its spread to adjacent tissue depend on its ability to stimulate\nangiogenesis. Angiogenesis consists of formation of new blood vessels from\npre-existing vasculature [<xref ref-type=\"bibr\" rid=\"CR6\">6</xref>]. The studies\nhave shown that the angiogenic potential of a tumor may be inferred from its\nvascularity measured in histological section [<xref ref-type=\"bibr\" rid=\"CR7\">7</xref>].\nThe count of blood microvessels of the tumor, as shown in microvessel density (MVD),\nhas been recognized as an indicator of malignant potential of the tumors and\nprovides the ability to predict tumor recurrence and survival. Endoglin (CD105) has\nbeen suggested to be the most suitable marker available to quantify tumor\nangiogenesis [<xref ref-type=\"bibr\" rid=\"CR8\">8</xref>].</p>\n",
                            "<p>We studied 95 cases of primary rectal adenocarcinomas in stage II (T3\u2013T4,\nN0, M0) treated by complete surgical resection (R0) in a 5-year period at Clinic\nfor Surgery, Clinical Hospital Center Rijeka, Croatia, from January 2002 to\nDecember 2006. The study included 95 primary rectal adenocarcinomas, 95 surgical\ndistal resection margin specimens, and 95 surgical proximal resection margin\nspecimens from surgical resection samples. The distal resection margin (DRM) and\nproximal resection margin (PRM) corresponding to the primary tumor from the same\npatients was taken from the margin of near and distant surgical resection.\nTissue samples included in this study were retrieved from the archives of the\nInstitute of Pathology School of Medicine of Rijeka, Croatia. The exclusion\ncriteria were a synchronous tumor or tumors in another localization in\nanamnesis, emergency surgery, preoperative radiotherapy or chemotherapy,\nperforation of bowel, and incomplete clinical data. The study was approved by\nthe University of Rijeka Ethics Committee and patients signed informed consent.</p>\n",
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>Immunohistochemical analysis was performed on formalin-fixed paraffin-embedded\nsection. All tissue samples from RC, DRM, and PRM were fixed in 10\u00a0%\nbuffered formalin and embedded in paraffin. We prepared 4-\u03bcm-thick\nserial section which were deparaffinized in xylene, rehydrated in graded\nethanol, and washed with phosphate-buffered saline. Endogenous peroxidase was\ninhibited with 3\u00a0% hydrogen peroxide. Tissue sections were incubated for\n30\u00a0min with the anti-CD105 primary monoclonal antibody (mouse\nanti-human, clone SN6h, Dako Corporation, Denmark) at a 1:10 dilution. Primary\nantibody binding site was visualized using a secondary antibody detection kit\n(Envision + kit; Dako, Denmark).</p>\n",
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>Stage II RC is defined by the presence of penetration through the muscularis propria\nand the absence of metastasis to either regional lymph nodes or distant sites [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>]. Rectal cancer surgery is effective for\nlocalized disease; however, approximately 25\u201330\u00a0% patients with\nstage II disease are at high risk for postoperative recurrence, and the clinical\noutcome of these patients is similar to that of patients with stage III disease [<xref ref-type=\"bibr\" rid=\"CR14\">14</xref>]. Identifying high-risk patients with stage\nII RC is important because it may help to identify patients and additional risk for\nwhom surgery alone may not be a curative treatment. During the past two decades,\nmany clinicopathologic studies indicate the importance of tumor angiogenic activity\nin defining the aggressiveness of tumor behavior [<xref ref-type=\"bibr\" rid=\"CR15\">\n15</xref>]. The microvessel density (MVD), which is based on the morphological\nvisualization and quantification of blood vessels, represents a possible prognostic\nvalue in colorectal cancer [<xref ref-type=\"bibr\" rid=\"CR16\">16</xref>]. Over the\npast decade, numerous studies have investigated the value of angiogenesis markers in\nCRC. Endoglin is a proliferation-associated antigen on endothelial cells and\nessential for angiogenesis. It has been reported that expression of the endoglin in\ntumor endothelium may be a prognostic indicator of the outcome for various human\ntumors including and colorectal cancer (CRC) [<xref ref-type=\"bibr\" rid=\"CR17\">17</xref>].\nMany angiogenesis markers have been studied but have not been used in conjunction\nwith the angiogenesis in the surgical resection margins.</p>\n",
                            "<p>Microvessel density assessment is the most commonly used technique to quantify\nintra-tumoral angiogenesis in cancer. In the present study, we assessed MVD with\nCD105 marker in RC tissue, distal resection margin, and proximal resection margin.\nIn our cohort, endoglin microvessel immunostaining was consistently present in all\nthe cases studied. We showed that the CD105-MVD values significantly increase in RC\nfrom the proximal and distal resection margin to the primary tumor (Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). These results support the role of CD105 as\nan optimal marker of proliferation of endothelial cells and its potential as\nprognostic factor [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>, <xref ref-type=\"bibr\" rid=\"CR14\">14</xref>, <xref ref-type=\"bibr\" rid=\"CR18\">18</xref>]. In our study,\noverall 5-year recurrence rate for all patients included in this study was\n16.8\u00a0%.</p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n",
                            "<p>We hypothesize that a crosstalk exists between rectal tumor cells and adjacent mucosa\nof distal margin. Tumor secretes cytokines and other signaling proteins which induce\nangiogenesis in the adjacent mucosa of distal margin [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. TGF-\u03b21, a multifunctional cytokine, has a complex\nrole in angiogenesis. It is expressed in number of cell types, including endothelial\ncells, depending on the concentration, is both pro angiogenic and antiangiogenic [<xref ref-type=\"bibr\" rid=\"CR36\">36</xref>]. One molecule that may orchestrate this\nbalance is endoglin [<xref ref-type=\"bibr\" rid=\"CR37\">37</xref>]. Endoglin is an\nauxiliary membrane receptor for transforming growth factor beta (TGF-\u03b2) that\nmodulates TGF-\u03b2 signaling [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>].\nRecently, endoglin has been identified as a key regulator of tumor cells\nproliferation, migration, and invasion [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>, <xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Craft et al. showed that endoglin\nexpression was lost during prostate cancer cell progression, and that led to\nincreased cell invasion and migration [<xref ref-type=\"bibr\" rid=\"CR38\">38</xref>].\nIt has been suggested that endoglin deficiency results in angiogenic adaptation,\nweakens the endothelial barrier, and increased metastatic spread and may be\nassociated with cancer progression [<xref ref-type=\"bibr\" rid=\"CR39\">39</xref>].</p>\n"
                        ]
                    },
                    {
                        "content": "Histologic type",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Adenocarcinoma",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "82",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "Adenocarcinoma with mucinous features",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "13",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Stage II RC is defined by the presence of penetration through the muscularis propria\nand the absence of metastasis to either regional lymph nodes or distant sites [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>]. Rectal cancer surgery is effective for\nlocalized disease; however, approximately 25\u201330\u00a0% patients with\nstage II disease are at high risk for postoperative recurrence, and the clinical\noutcome of these patients is similar to that of patients with stage III disease [<xref ref-type=\"bibr\" rid=\"CR14\">14</xref>]. Identifying high-risk patients with stage\nII RC is important because it may help to identify patients and additional risk for\nwhom surgery alone may not be a curative treatment. During the past two decades,\nmany clinicopathologic studies indicate the importance of tumor angiogenic activity\nin defining the aggressiveness of tumor behavior [<xref ref-type=\"bibr\" rid=\"CR15\">\n15</xref>]. The microvessel density (MVD), which is based on the morphological\nvisualization and quantification of blood vessels, represents a possible prognostic\nvalue in colorectal cancer [<xref ref-type=\"bibr\" rid=\"CR16\">16</xref>]. Over the\npast decade, numerous studies have investigated the value of angiogenesis markers in\nCRC. Endoglin is a proliferation-associated antigen on endothelial cells and\nessential for angiogenesis. It has been reported that expression of the endoglin in\ntumor endothelium may be a prognostic indicator of the outcome for various human\ntumors including and colorectal cancer (CRC) [<xref ref-type=\"bibr\" rid=\"CR17\">17</xref>].\nMany angiogenesis markers have been studied but have not been used in conjunction\nwith the angiogenesis in the surgical resection margins.</p>\n",
                            "<p>Microvessel density assessment is the most commonly used technique to quantify\nintra-tumoral angiogenesis in cancer. In the present study, we assessed MVD with\nCD105 marker in RC tissue, distal resection margin, and proximal resection margin.\nIn our cohort, endoglin microvessel immunostaining was consistently present in all\nthe cases studied. We showed that the CD105-MVD values significantly increase in RC\nfrom the proximal and distal resection margin to the primary tumor (Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). These results support the role of CD105 as\nan optimal marker of proliferation of endothelial cells and its potential as\nprognostic factor [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>, <xref ref-type=\"bibr\" rid=\"CR14\">14</xref>, <xref ref-type=\"bibr\" rid=\"CR18\">18</xref>]. In our study,\noverall 5-year recurrence rate for all patients included in this study was\n16.8\u00a0%.</p>\n"
                        ]
                    },
                    {
                        "content": "Depth of tumor invasion",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "T3",
                        "cited_in": [
                            "<p>We studied 95 cases of primary rectal adenocarcinomas in stage II (T3\u2013T4,\nN0, M0) treated by complete surgical resection (R0) in a 5-year period at Clinic\nfor Surgery, Clinical Hospital Center Rijeka, Croatia, from January 2002 to\nDecember 2006. The study included 95 primary rectal adenocarcinomas, 95 surgical\ndistal resection margin specimens, and 95 surgical proximal resection margin\nspecimens from surgical resection samples. The distal resection margin (DRM) and\nproximal resection margin (PRM) corresponding to the primary tumor from the same\npatients was taken from the margin of near and distant surgical resection.\nTissue samples included in this study were retrieved from the archives of the\nInstitute of Pathology School of Medicine of Rijeka, Croatia. The exclusion\ncriteria were a synchronous tumor or tumors in another localization in\nanamnesis, emergency surgery, preoperative radiotherapy or chemotherapy,\nperforation of bowel, and incomplete clinical data. The study was approved by\nthe University of Rijeka Ethics Committee and patients signed informed consent.</p>\n",
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "37",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>We hypothesize that a crosstalk exists between rectal tumor cells and adjacent mucosa\nof distal margin. Tumor secretes cytokines and other signaling proteins which induce\nangiogenesis in the adjacent mucosa of distal margin [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. TGF-\u03b21, a multifunctional cytokine, has a complex\nrole in angiogenesis. It is expressed in number of cell types, including endothelial\ncells, depending on the concentration, is both pro angiogenic and antiangiogenic [<xref ref-type=\"bibr\" rid=\"CR36\">36</xref>]. One molecule that may orchestrate this\nbalance is endoglin [<xref ref-type=\"bibr\" rid=\"CR37\">37</xref>]. Endoglin is an\nauxiliary membrane receptor for transforming growth factor beta (TGF-\u03b2) that\nmodulates TGF-\u03b2 signaling [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>].\nRecently, endoglin has been identified as a key regulator of tumor cells\nproliferation, migration, and invasion [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>, <xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Craft et al. showed that endoglin\nexpression was lost during prostate cancer cell progression, and that led to\nincreased cell invasion and migration [<xref ref-type=\"bibr\" rid=\"CR38\">38</xref>].\nIt has been suggested that endoglin deficiency results in angiogenic adaptation,\nweakens the endothelial barrier, and increased metastatic spread and may be\nassociated with cancer progression [<xref ref-type=\"bibr\" rid=\"CR39\">39</xref>].</p>\n"
                        ]
                    },
                    {
                        "content": "T4a",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "42",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "T4b",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "16",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Stage II RC is defined by the presence of penetration through the muscularis propria\nand the absence of metastasis to either regional lymph nodes or distant sites [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>]. Rectal cancer surgery is effective for\nlocalized disease; however, approximately 25\u201330\u00a0% patients with\nstage II disease are at high risk for postoperative recurrence, and the clinical\noutcome of these patients is similar to that of patients with stage III disease [<xref ref-type=\"bibr\" rid=\"CR14\">14</xref>]. Identifying high-risk patients with stage\nII RC is important because it may help to identify patients and additional risk for\nwhom surgery alone may not be a curative treatment. During the past two decades,\nmany clinicopathologic studies indicate the importance of tumor angiogenic activity\nin defining the aggressiveness of tumor behavior [<xref ref-type=\"bibr\" rid=\"CR15\">\n15</xref>]. The microvessel density (MVD), which is based on the morphological\nvisualization and quantification of blood vessels, represents a possible prognostic\nvalue in colorectal cancer [<xref ref-type=\"bibr\" rid=\"CR16\">16</xref>]. Over the\npast decade, numerous studies have investigated the value of angiogenesis markers in\nCRC. Endoglin is a proliferation-associated antigen on endothelial cells and\nessential for angiogenesis. It has been reported that expression of the endoglin in\ntumor endothelium may be a prognostic indicator of the outcome for various human\ntumors including and colorectal cancer (CRC) [<xref ref-type=\"bibr\" rid=\"CR17\">17</xref>].\nMany angiogenesis markers have been studied but have not been used in conjunction\nwith the angiogenesis in the surgical resection margins.</p>\n",
                            "<p>Microvessel density assessment is the most commonly used technique to quantify\nintra-tumoral angiogenesis in cancer. In the present study, we assessed MVD with\nCD105 marker in RC tissue, distal resection margin, and proximal resection margin.\nIn our cohort, endoglin microvessel immunostaining was consistently present in all\nthe cases studied. We showed that the CD105-MVD values significantly increase in RC\nfrom the proximal and distal resection margin to the primary tumor (Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). These results support the role of CD105 as\nan optimal marker of proliferation of endothelial cells and its potential as\nprognostic factor [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>, <xref ref-type=\"bibr\" rid=\"CR14\">14</xref>, <xref ref-type=\"bibr\" rid=\"CR18\">18</xref>]. In our study,\noverall 5-year recurrence rate for all patients included in this study was\n16.8\u00a0%.</p>\n"
                        ]
                    },
                    {
                        "content": "Tumor size",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "\u22644\u00a0cm",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "64",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n"
                        ]
                    },
                    {
                        "content": ">4\u00a0cm",
                        "cited_in": []
                    },
                    {
                        "content": "31",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Furthermore, significantly higher rates of tumor recurrence were found in patients\nwith lower MVD in tumors than in cut-off value obtained by ROC analysis. This is\nshown by Kaplan-Meier recurrence curve for MVD in RC tissue (Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>). Our results suggest that the lower\nCD105-MVD is accompanied by higher rate of tumor recurrence, which is not in\naccordance with the results that an increased CD105-MVD was correlated with\nrecurrence of the disease after radical resection. In their study, Skoufi et al.\nhave found a strong association between increased CD105-MVD and recurrence of CRC [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>]. Chen et al. have reported that the RC\nwith higher MVD are more likely to recur or metastasize after radical resection\n(CD31 immunostaining, average as cut-off) [<xref ref-type=\"bibr\" rid=\"CR28\">28</xref>].\nOther studies demonstrated that high MVD counts determined using CD105 were strongly\nassociated with high risk of metastatic disease (Saad et al., Romani et al., median\nas cut-off) [<xref ref-type=\"bibr\" rid=\"CR29\">29</xref>, <xref ref-type=\"bibr\" rid=\"CR30\">30</xref>]. According to the results in the study of Uribarrena et\nal., patients with stage I and II colorectal carcinomas with higher vascularized\ntumor area had a significant association with a better outcome, but no significant\nrelationship was observed between MVD and tumor recurrence and death [<xref ref-type=\"bibr\" rid=\"CR31\">31</xref>]. Some studies reveal that MVD determined\nwith CD105 is not correlated with recurrence rate [<xref ref-type=\"bibr\" rid=\"CR32\">\n32</xref>, <xref ref-type=\"bibr\" rid=\"CR33\">33</xref>].</p>\n"
                        ]
                    },
                    {
                        "content": "Tumor recurrence",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>Statistical analysis was performed using MedCalc version 14.8.1 (MedCalc Software\nbvba, Mariakerke, Belgium). Descriptive statistics and 95\u00a0% confidence\nintervals were calculated to describe data. The distribution of data was tested\nfor normality using the Smirnov-Kolmogorov test. The Mann-Whitney <italic>U</italic>\ntest and Kruskal-Wallis tests were used to compare MVD among the\nclinicopathological variables. Spearman\u2019s rho correlation was used to\ntest the correlation between the immunohistochemical findings and tumor\nrecurrence. The receiver operating characteristic (ROC) curve approach was used\nto determine best-fitting cut-off for the MVD in terms of the tumor recurrence\nanalysis [<xref ref-type=\"bibr\" rid=\"CR12\">12</xref>]. Tumor recurrence analysis\nwas estimated by the Kaplan-Meier method and compared by the log rank test.\nPrognostic factors of tumor recurrence were identified by the use of the Cox\nproportional hazard regression. Differences at <italic>p</italic>\u2009&lt;\u20090.05\nwere considered significant.</p>\n"
                        ]
                    },
                    {
                        "content": "Yes",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "16",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Stage II RC is defined by the presence of penetration through the muscularis propria\nand the absence of metastasis to either regional lymph nodes or distant sites [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>]. Rectal cancer surgery is effective for\nlocalized disease; however, approximately 25\u201330\u00a0% patients with\nstage II disease are at high risk for postoperative recurrence, and the clinical\noutcome of these patients is similar to that of patients with stage III disease [<xref ref-type=\"bibr\" rid=\"CR14\">14</xref>]. Identifying high-risk patients with stage\nII RC is important because it may help to identify patients and additional risk for\nwhom surgery alone may not be a curative treatment. During the past two decades,\nmany clinicopathologic studies indicate the importance of tumor angiogenic activity\nin defining the aggressiveness of tumor behavior [<xref ref-type=\"bibr\" rid=\"CR15\">\n15</xref>]. The microvessel density (MVD), which is based on the morphological\nvisualization and quantification of blood vessels, represents a possible prognostic\nvalue in colorectal cancer [<xref ref-type=\"bibr\" rid=\"CR16\">16</xref>]. Over the\npast decade, numerous studies have investigated the value of angiogenesis markers in\nCRC. Endoglin is a proliferation-associated antigen on endothelial cells and\nessential for angiogenesis. It has been reported that expression of the endoglin in\ntumor endothelium may be a prognostic indicator of the outcome for various human\ntumors including and colorectal cancer (CRC) [<xref ref-type=\"bibr\" rid=\"CR17\">17</xref>].\nMany angiogenesis markers have been studied but have not been used in conjunction\nwith the angiogenesis in the surgical resection margins.</p>\n",
                            "<p>Microvessel density assessment is the most commonly used technique to quantify\nintra-tumoral angiogenesis in cancer. In the present study, we assessed MVD with\nCD105 marker in RC tissue, distal resection margin, and proximal resection margin.\nIn our cohort, endoglin microvessel immunostaining was consistently present in all\nthe cases studied. We showed that the CD105-MVD values significantly increase in RC\nfrom the proximal and distal resection margin to the primary tumor (Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). These results support the role of CD105 as\nan optimal marker of proliferation of endothelial cells and its potential as\nprognostic factor [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>, <xref ref-type=\"bibr\" rid=\"CR14\">14</xref>, <xref ref-type=\"bibr\" rid=\"CR18\">18</xref>]. In our study,\noverall 5-year recurrence rate for all patients included in this study was\n16.8\u00a0%.</p>\n"
                        ]
                    },
                    {
                        "content": "No",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "79",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n"
                        ]
                    }
                ]
            },
            {
                "table_id": "Tab2",
                "body": "<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n",
                "caption": "<p>Univariate analysis for tumor recurrence</p>\n",
                "foots": [
                    "<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n",
                    "<p>*log-rank test</p>\n"
                ],
                "paragraphs": [
                    {
                        "text": "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                        "citations": []
                    },
                    {
                        "text": "<p>Recurrence rates in our cohort stage II RC patients were analyzed according to age,\ngender, surgery, tumor location, grade of differentiation, histology, depth of tumor\ninvasion, and tumor size (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>).\nBy univariate analysis, only the type of surgical resection was found to be\nsignificant prognostic factors for tumor recurrence. Patients treated with a primary\nAPR had a higher rate of tumor recurrence than those who underwent a LAR, which is\nin accordance with the results of most of the authors [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>]. Previous studies have demonstrated an LAR to APR ratio\n3:1 or 4:1 which is consistent with our results [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>\n, <xref ref-type=\"bibr\" rid=\"CR20\">20</xref>]. However, most studies were too small\nto adequately evaluate the relationship between the type surgery and tumor\nrecurrence (TR). The key to successful surgery is complete excision of the tumor\nwith sufficient margin of normal tissue. TR may also sometimes occur even in the\nabsence of an involved CRM possibly owing to lymphatic spread from the distal rectum\nto lymph nodes in the pelvic side wall [<xref ref-type=\"bibr\" rid=\"CR21\">21</xref>].\nIn low rectal cancer, total mesorectal excision (TME) surgery may be insufficient to\nobtain the desired CRM because of lack of mesorectum at the level of the pelvic\nfloor [<xref ref-type=\"bibr\" rid=\"CR22\">22</xref>]. APR surgery frequently results\nin perineal and presacral TR [<xref ref-type=\"bibr\" rid=\"CR23\">23</xref>]. The\nchoice of surgical resection is limited and influenced by tumor staging, tumor\nlocation, and intrapelvic tumor invasion at the time of the diagnosis [<xref ref-type=\"bibr\" rid=\"CR24\">24</xref>].</p>\n",
                        "citations": [
                            "<ref id=\"CR19\">\n<label>19.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Wang</surname>\n<given-names>X-T</given-names>\n</name>\n<name>\n<surname>Li</surname>\n<given-names>D-G</given-names>\n</name>\n<name>\n<surname>Li</surname>\n<given-names>L</given-names>\n</name>\n<name>\n<surname>Kong</surname>\n<given-names>F-B</given-names>\n</name>\n<name>\n<surname>Pang</surname>\n<given-names>L-M</given-names>\n</name>\n<name>\n<surname>Mai</surname>\n<given-names>W</given-names>\n</name>\n</person-group>\n<article-title>Mata-analysis of oncological outcome after abdominoperineal\nresection or low anterior resection for lower rectal cancer</article-title>\n<source>Pathol Oncol Res</source>\n<year>2015</year>\n<volume>21</volume>\n<fpage>19</fpage>\n<lpage>27</lpage>\n<pub-id pub-id-type=\"doi\">10.1007/s12253-014-9863-x</pub-id>\n<pub-id pub-id-type=\"pmid\">25430561</pub-id>\n</element-citation>\n</ref>\n",
                            "<ref id=\"CR19\">\n<label>19.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Wang</surname>\n<given-names>X-T</given-names>\n</name>\n<name>\n<surname>Li</surname>\n<given-names>D-G</given-names>\n</name>\n<name>\n<surname>Li</surname>\n<given-names>L</given-names>\n</name>\n<name>\n<surname>Kong</surname>\n<given-names>F-B</given-names>\n</name>\n<name>\n<surname>Pang</surname>\n<given-names>L-M</given-names>\n</name>\n<name>\n<surname>Mai</surname>\n<given-names>W</given-names>\n</name>\n</person-group>\n<article-title>Mata-analysis of oncological outcome after abdominoperineal\nresection or low anterior resection for lower rectal cancer</article-title>\n<source>Pathol Oncol Res</source>\n<year>2015</year>\n<volume>21</volume>\n<fpage>19</fpage>\n<lpage>27</lpage>\n<pub-id pub-id-type=\"doi\">10.1007/s12253-014-9863-x</pub-id>\n<pub-id pub-id-type=\"pmid\">25430561</pub-id>\n</element-citation>\n</ref>\n",
                            "<ref id=\"CR20\">\n<label>20.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Perry</surname>\n<given-names>WB</given-names>\n</name>\n<name>\n<surname>Connaughton</surname>\n<given-names>JC</given-names>\n</name>\n</person-group>\n<article-title>Abdominoperineal resection: how is it done and wath are results?</article-title>\n<source>Clin Colon Rectal Surg</source>\n<year>2007</year>\n<volume>20</volume>\n<issue>3</issue>\n<fpage>213</fpage>\n<lpage>20</lpage>\n<pub-id pub-id-type=\"doi\">10.1055/s-2007-984865</pub-id>\n<pub-id pub-id-type=\"pmid\">20011202</pub-id>\n</element-citation>\n</ref>\n",
                            "<ref id=\"CR21\">\n<label>21.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Moriya</surname>\n<given-names>Y</given-names>\n</name>\n<name>\n<surname>Sugihara</surname>\n<given-names>K</given-names>\n</name>\n<name>\n<surname>Akasu</surname>\n<given-names>T</given-names>\n</name>\n<name>\n<surname>Fujita</surname>\n<given-names>S</given-names>\n</name>\n</person-group>\n<article-title>Patterns of recurrence after nerve-sparing surgery for rectal\nadenocarcinoma with special reference to loco-regional recurrence</article-title>\n<source>Dis Colon Rectum</source>\n<year>1995</year>\n<volume>38</volume>\n<fpage>1162</fpage>\n<lpage>8</lpage>\n<pub-id pub-id-type=\"doi\">10.1007/BF02048331</pub-id>\n<pub-id pub-id-type=\"pmid\">7587758</pub-id>\n</element-citation>\n</ref>\n",
                            "<ref id=\"CR22\">\n<label>22.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Bujanda</surname>\n<given-names>L</given-names>\n</name>\n</person-group>\n<article-title>Patterns of local recurrence in rectal cancer after a\nmultidisciplinary approach</article-title>\n<source>World J Gastroenterol</source>\n<year>2011</year>\n<volume>17</volume>\n<fpage>1674</fpage>\n<lpage>84</lpage>\n<pub-id pub-id-type=\"doi\">10.3748/wjg.v17.i13.1674</pub-id>\n<pub-id pub-id-type=\"pmid\">21483626</pub-id>\n</element-citation>\n</ref>\n",
                            "<ref id=\"CR23\">\n<label>23.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>West</surname>\n<given-names>NP</given-names>\n</name>\n<name>\n<surname>Anderin</surname>\n<given-names>C</given-names>\n</name>\n<name>\n<surname>Smith</surname>\n<given-names>KJ</given-names>\n</name>\n<name>\n<surname>Holm</surname>\n<given-names>T</given-names>\n</name>\n<name>\n<surname>Quirke</surname>\n<given-names>P</given-names>\n</name>\n</person-group>\n<article-title>Multicentre experience with extralevator abdominoperineal\nexcision for low rectal cancer</article-title>\n<source>Br J Surg</source>\n<year>2010</year>\n<volume>97</volume>\n<fpage>588</fpage>\n<lpage>99</lpage>\n<pub-id pub-id-type=\"doi\">10.1002/bjs.6916</pub-id>\n<pub-id pub-id-type=\"pmid\">20186891</pub-id>\n</element-citation>\n</ref>\n",
                            "<ref id=\"CR24\">\n<label>24.</label>\n<element-citation publication-type=\"journal\">\n<person-group person-group-type=\"author\">\n<name>\n<surname>Cai</surname>\n<given-names>Y</given-names>\n</name>\n<name>\n<surname>Li</surname>\n<given-names>Z</given-names>\n</name>\n<name>\n<surname>Gu</surname>\n<given-names>X</given-names>\n</name>\n<name>\n<surname>Fang</surname>\n<given-names>Y</given-names>\n</name>\n<name>\n<surname>Xiang</surname>\n<given-names>J</given-names>\n</name>\n<name>\n<surname>Chen</surname>\n<given-names>Z</given-names>\n</name>\n</person-group>\n<article-title>Prognostic factors associated with locally recurrent rectal\ncancer following primary surgery (review)</article-title>\n<source>Oncol Lett</source>\n<year>2014</year>\n<volume>7</volume>\n<fpage>10</fpage>\n<lpage>6</lpage>\n<pub-id pub-id-type=\"pmid\">24348812</pub-id>\n</element-citation>\n</ref>\n"
                        ]
                    }
                ],
                "cells": [
                    {
                        "content": "Age (median)",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.716",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "\u226469",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": ">69",
                        "cited_in": []
                    },
                    {
                        "content": "0.839",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.310\u20132.268",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Gender",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.142",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Male",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Female",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.426",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.152\u20131.190",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Type of surgery",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.010",
                        "cited_in": [
                            "<p>The MVD was significantly higher in the tumor samples compared with the\ndistal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001).\nThere was no significant difference in the MVD between distal and proximal\nresection margins (<italic>p</italic>\u2009=\u20090.147). The type of\nsurgical resection was a significant factor for determining the recurrence\nof tumors (<italic>p</italic>\u2009=\u20090.0104). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade\nof differentiation, histological tumor type, and the size and depth of tumor\ninvasion on the recurrence of the tumor. The recurrence rate was\nsignificantly higher in the low CD105-MVD group of patients than in the high\nCD105-MVD group of patients (log rank test, <italic>p</italic>\u2009=\u20090.0406).\nResult of the multivariate analysis showed that the type of surgery (<italic>\np</italic>\u2009=\u20090.0086), MVD tumors (<italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (<italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for the recurrent tumors.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Low anterior resection",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Abdominoperineal resection",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "3.140",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.919\u201310.725",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Tumor location",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.710",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Upper rectum",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Middle rectum",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.267",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.381\u20134.213",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Low rectum",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.716",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.419\u20137.026",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Grade of differentiation",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.936",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "G1",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "G2",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.933",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.416\u20133.423",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "G3",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.119",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.137\u20139.137",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Histologic type",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.299",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Adenocarcinoma",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Adenocarcinoma with mucinous features",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.381",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.096\u20131.514",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Depth of tumor invasion",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.925",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "T3",
                        "cited_in": [
                            "<p>We studied 95 cases of primary rectal adenocarcinomas in stage II (T3\u2013T4,\nN0, M0) treated by complete surgical resection (R0) in a 5-year period at Clinic\nfor Surgery, Clinical Hospital Center Rijeka, Croatia, from January 2002 to\nDecember 2006. The study included 95 primary rectal adenocarcinomas, 95 surgical\ndistal resection margin specimens, and 95 surgical proximal resection margin\nspecimens from surgical resection samples. The distal resection margin (DRM) and\nproximal resection margin (PRM) corresponding to the primary tumor from the same\npatients was taken from the margin of near and distant surgical resection.\nTissue samples included in this study were retrieved from the archives of the\nInstitute of Pathology School of Medicine of Rijeka, Croatia. The exclusion\ncriteria were a synchronous tumor or tumors in another localization in\nanamnesis, emergency surgery, preoperative radiotherapy or chemotherapy,\nperforation of bowel, and incomplete clinical data. The study was approved by\nthe University of Rijeka Ethics Committee and patients signed informed consent.</p>\n",
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "T4a",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.919",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.316\u20132.673",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "T4b",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.745",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.172\u20133.223",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "Tumor size",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.329",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "\u22644\u00a0cm",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "1.000",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": ">4\u00a0cm",
                        "cited_in": []
                    },
                    {
                        "content": "0.594",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "0.214\u20131.651",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n"
                        ]
                    }
                ]
            },
            {
                "table_id": "Tab3",
                "body": "<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n",
                "caption": "<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n",
                "foots": [
                    "<p>\n<italic>AUC</italic> area under the curve</p>\n"
                ],
                "paragraphs": [
                    {
                        "text": "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                        "citations": []
                    }
                ],
                "cells": [
                    {
                        "content": "MVD in tumors",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>Furthermore, significantly higher rates of tumor recurrence were found in patients\nwith lower MVD in tumors than in cut-off value obtained by ROC analysis. This is\nshown by Kaplan-Meier recurrence curve for MVD in RC tissue (Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>). Our results suggest that the lower\nCD105-MVD is accompanied by higher rate of tumor recurrence, which is not in\naccordance with the results that an increased CD105-MVD was correlated with\nrecurrence of the disease after radical resection. In their study, Skoufi et al.\nhave found a strong association between increased CD105-MVD and recurrence of CRC [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>]. Chen et al. have reported that the RC\nwith higher MVD are more likely to recur or metastasize after radical resection\n(CD31 immunostaining, average as cut-off) [<xref ref-type=\"bibr\" rid=\"CR28\">28</xref>].\nOther studies demonstrated that high MVD counts determined using CD105 were strongly\nassociated with high risk of metastatic disease (Saad et al., Romani et al., median\nas cut-off) [<xref ref-type=\"bibr\" rid=\"CR29\">29</xref>, <xref ref-type=\"bibr\" rid=\"CR30\">30</xref>]. According to the results in the study of Uribarrena et\nal., patients with stage I and II colorectal carcinomas with higher vascularized\ntumor area had a significant association with a better outcome, but no significant\nrelationship was observed between MVD and tumor recurrence and death [<xref ref-type=\"bibr\" rid=\"CR31\">31</xref>]. Some studies reveal that MVD determined\nwith CD105 is not correlated with recurrence rate [<xref ref-type=\"bibr\" rid=\"CR32\">\n32</xref>, <xref ref-type=\"bibr\" rid=\"CR33\">33</xref>].</p>\n",
                            "<p>In the present study, we found a significant inverse correlation between the\nCD105-MVD in the distal resection margins and the length of DRM that were closest to\nthe RC. This analysis suggested an active reaction of the adjacent mucosa related to\nthe presence of the tumor, but a more passive reaction induced by the factors\nreleased from the tumor [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. Also, our\nresult shows a significant correlation between the CD105-MVD and tumor recurrence:\nsignificantly higher rates of tumor recurrence were found in patients with higher\nCD105-MVD in distal resection margins than cut-off value obtained by ROC analysis.\nRegarding the pattern of recurrence after surgery alone, we revealed that lower\nCD105-MVD in tumors and higher CD105-MVD in distal resection margins significantly\ncorrelated with tumor recurrence, suggesting that CD105 may be involved in\ndeveloping tumor recurrence in rectal cancer. However, the results of different\nstudies are linking the lower tumor vascularity with poor outcomes and in various\nother solid tumors [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Only recently\nacquired knowledge has led to the conclusions that the local tissue microenvironment\ncontributes significantly to tumor progression.</p>\n"
                        ]
                    },
                    {
                        "content": "0.601",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "106.2",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "56.2",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "81.0",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in DRM",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.656",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "186.3",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "37.5",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "91.1",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in PRM",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.602",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "27.8",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "43.7",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "81.0",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    }
                ]
            },
            {
                "table_id": "Tab4",
                "body": "<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n",
                "caption": "<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n",
                "foots": [
                    "<p>*log-rank test</p>\n"
                ],
                "paragraphs": [
                    {
                        "text": "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                        "citations": []
                    }
                ],
                "cells": [
                    {
                        "content": "MVD in tumors",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                            "<p>Furthermore, significantly higher rates of tumor recurrence were found in patients\nwith lower MVD in tumors than in cut-off value obtained by ROC analysis. This is\nshown by Kaplan-Meier recurrence curve for MVD in RC tissue (Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>). Our results suggest that the lower\nCD105-MVD is accompanied by higher rate of tumor recurrence, which is not in\naccordance with the results that an increased CD105-MVD was correlated with\nrecurrence of the disease after radical resection. In their study, Skoufi et al.\nhave found a strong association between increased CD105-MVD and recurrence of CRC [<xref ref-type=\"bibr\" rid=\"CR27\">27</xref>]. Chen et al. have reported that the RC\nwith higher MVD are more likely to recur or metastasize after radical resection\n(CD31 immunostaining, average as cut-off) [<xref ref-type=\"bibr\" rid=\"CR28\">28</xref>].\nOther studies demonstrated that high MVD counts determined using CD105 were strongly\nassociated with high risk of metastatic disease (Saad et al., Romani et al., median\nas cut-off) [<xref ref-type=\"bibr\" rid=\"CR29\">29</xref>, <xref ref-type=\"bibr\" rid=\"CR30\">30</xref>]. According to the results in the study of Uribarrena et\nal., patients with stage I and II colorectal carcinomas with higher vascularized\ntumor area had a significant association with a better outcome, but no significant\nrelationship was observed between MVD and tumor recurrence and death [<xref ref-type=\"bibr\" rid=\"CR31\">31</xref>]. Some studies reveal that MVD determined\nwith CD105 is not correlated with recurrence rate [<xref ref-type=\"bibr\" rid=\"CR32\">\n32</xref>, <xref ref-type=\"bibr\" rid=\"CR33\">33</xref>].</p>\n",
                            "<p>In the present study, we found a significant inverse correlation between the\nCD105-MVD in the distal resection margins and the length of DRM that were closest to\nthe RC. This analysis suggested an active reaction of the adjacent mucosa related to\nthe presence of the tumor, but a more passive reaction induced by the factors\nreleased from the tumor [<xref ref-type=\"bibr\" rid=\"CR34\">34</xref>]. Also, our\nresult shows a significant correlation between the CD105-MVD and tumor recurrence:\nsignificantly higher rates of tumor recurrence were found in patients with higher\nCD105-MVD in distal resection margins than cut-off value obtained by ROC analysis.\nRegarding the pattern of recurrence after surgery alone, we revealed that lower\nCD105-MVD in tumors and higher CD105-MVD in distal resection margins significantly\ncorrelated with tumor recurrence, suggesting that CD105 may be involved in\ndeveloping tumor recurrence in rectal cancer. However, the results of different\nstudies are linking the lower tumor vascularity with poor outcomes and in various\nother solid tumors [<xref ref-type=\"bibr\" rid=\"CR35\">35</xref>]. Only recently\nacquired knowledge has led to the conclusions that the local tissue microenvironment\ncontributes significantly to tumor progression.</p>\n"
                        ]
                    },
                    {
                        "content": "0.0008",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "\u2264106.2",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "24",
                        "cited_in": [
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Recurrence rates in our cohort stage II RC patients were analyzed according to age,\ngender, surgery, tumor location, grade of differentiation, histology, depth of tumor\ninvasion, and tumor size (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>).\nBy univariate analysis, only the type of surgical resection was found to be\nsignificant prognostic factors for tumor recurrence. Patients treated with a primary\nAPR had a higher rate of tumor recurrence than those who underwent a LAR, which is\nin accordance with the results of most of the authors [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>]. Previous studies have demonstrated an LAR to APR ratio\n3:1 or 4:1 which is consistent with our results [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>\n, <xref ref-type=\"bibr\" rid=\"CR20\">20</xref>]. However, most studies were too small\nto adequately evaluate the relationship between the type surgery and tumor\nrecurrence (TR). The key to successful surgery is complete excision of the tumor\nwith sufficient margin of normal tissue. TR may also sometimes occur even in the\nabsence of an involved CRM possibly owing to lymphatic spread from the distal rectum\nto lymph nodes in the pelvic side wall [<xref ref-type=\"bibr\" rid=\"CR21\">21</xref>].\nIn low rectal cancer, total mesorectal excision (TME) surgery may be insufficient to\nobtain the desired CRM because of lack of mesorectum at the level of the pelvic\nfloor [<xref ref-type=\"bibr\" rid=\"CR22\">22</xref>]. APR surgery frequently results\nin perineal and presacral TR [<xref ref-type=\"bibr\" rid=\"CR23\">23</xref>]. The\nchoice of surgical resection is limited and influenced by tumor staging, tumor\nlocation, and intrapelvic tumor invasion at the time of the diagnosis [<xref ref-type=\"bibr\" rid=\"CR24\">24</xref>].</p>\n"
                        ]
                    },
                    {
                        "content": "37.5",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": ">106.2",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "71",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "9.8",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in DRM",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.0074",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "\u2264186.3",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "82",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "12.2",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": ">186.3",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "13",
                        "cited_in": [
                            "<p>All of the patients underwent radical low anterior resection (LAR) or\nabdominoperineal resection (APR). All patients had confirmed rectal\nadenocarcinomas by histopathology and were staged according to the 7th edition\nof the American Joint Committee on Cancer Staging Manual [<xref ref-type=\"bibr\" rid=\"CR9\">9</xref>]. The histological grading was classified according to\nthe World Health Organization (WHO) classification [<xref ref-type=\"bibr\" rid=\"CR10\">10</xref>]. The mean duration of follow-up was\n54.7\u2009\u00b1\u200923.1\u00a0months (median duration,\n60.0\u00a0months) after the operation for RC. Recurrence data and cause of\ndeath of those who died during follow-up period were obtained from the Croatian\nCancer Registry. Patient and tumor characteristics are presented in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>.\n<table-wrap id=\"Tab1\">\n<label>Table 1</label>\n<caption>\n<p>Clinical and pathologic characteristics of the rectal cancer samples</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Number of patients</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Total number</td>\n<td>95</td>\n</tr>\n<tr>\n<td colspan=\"2\">Age, median 69\u00a0years</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>49</td>\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>46</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gender</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>61</td>\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>34</td>\n</tr>\n<tr>\n<td colspan=\"2\">Type of surgery</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>76</td>\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor location</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>23</td>\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>52</td>\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\"2\">Grade of differentiation</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>55</td>\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>34</td>\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>6</td>\n</tr>\n<tr>\n<td colspan=\"2\">Histologic type</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>82</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>13</td>\n</tr>\n<tr>\n<td colspan=\"2\">Depth of tumor invasion</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>37</td>\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>42</td>\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>16</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor size</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>64</td>\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>31</td>\n</tr>\n<tr>\n<td colspan=\"2\">Tumor recurrence</td>\n</tr>\n<tr>\n<td>\u2003Yes</td>\n<td>16</td>\n</tr>\n<tr>\n<td>\u2003No</td>\n<td>79</td>\n</tr>\n</tbody>\n</table>\n</table-wrap></p>\n",
                            "<p>All slides stained with anti-CD105 were viewed and analyzed with Alphelys Spot\nBrowser 2 integrated system, using a software controlled (Alphelys Spot Browser\n2.4.4., France) stage positioning Nikon Eclipse 50i microscope mounted\n1360\u2009\u00d7\u20091024 resolution Microvision CFW-1310C digital\ncamera. The slides were scanned at \u00d720 magnification to identify\n\u201chot spots\u201d (areas with the highest microvessel concentration)\nfor the slides and then \u00d7200 magnification to create images for\nquantification scoring positive cells and MVD. Positive cells were counted in\nthe tumor, DRM, and PRM and presented as percentage of positive cells and MVD as\nnumber of microvessels in the histological field according to Weidner et al. [<xref ref-type=\"bibr\" rid=\"CR11\">11</xref>]. The regions with the most intensive\nvascularization (hot spots) were defined by scanning the entire tumor section at\nlow magnification with a selection of four fields. The areas of this\nhistological field was 0.612\u00a0mm<sup>2</sup>. Hot spots were identified\nby two independent observers at \u00d720 magnification.</p>\n",
                            "<p>We assessed paraffin-embedded specimens from tumors from the 95 patients resected\nfor RC. Clinicopathological characteristics of patients are summarized in\nTable\u00a0<xref rid=\"Tab1\" ref-type=\"table\">1</xref>. The median age at\ndiagnosis was 69\u00a0years (range 15 to 85\u00a0years), 49 patients\n(51.6\u00a0%) were \u226469\u00a0years of age, and 46 patients\n(48.4\u00a0%) were &gt;69\u00a0years old. Sixty-one (64.2\u00a0%)\nwere males and 34 (35.8\u00a0%) were females. In 23 patients\n(24.2\u00a0%), the tumor was located in the upper rectum, in 52\n(54.7\u00a0%), in the middle rectum and in 20 (21.1\u00a0%), in the low\nrectum. According to the grade of differentiation, 55 patients (57.9\u00a0%)\nwere G1 (well differentiated), 34 (35.8\u00a0%) G2 (moderately\ndifferentiated), and 6 (6.3\u00a0%) G3 (poorly differentiated). According to\nthe depth of tumor invasion, 37 patients (38.9\u00a0%) were T3, 42\n(44.2\u00a0%) T4a, and 16 (16.9\u00a0%) T4b. Eighty-two (86.3\u00a0%)\ntumors were classified as adenocarcinomas and 13 (13.7\u00a0%) as\nadenocarcinomas with mucinous features. Median tumor size was 3.8\u00a0cm\n(range, 1.3 to 12.0\u00a0cm). The median patients follow-up was\n60\u00a0months (range, 1.0 to 109.0\u00a0months). Of the 95 patients, 16\npatients developed recurrence of the tumor (recurrence rate, 16.8\u00a0%) and\n29 died of RC (overall survival rate, 30.5\u00a0%) in the 5-year follow-up\nperiod.</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Stage II RC is defined by the presence of penetration through the muscularis propria\nand the absence of metastasis to either regional lymph nodes or distant sites [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>]. Rectal cancer surgery is effective for\nlocalized disease; however, approximately 25\u201330\u00a0% patients with\nstage II disease are at high risk for postoperative recurrence, and the clinical\noutcome of these patients is similar to that of patients with stage III disease [<xref ref-type=\"bibr\" rid=\"CR14\">14</xref>]. Identifying high-risk patients with stage\nII RC is important because it may help to identify patients and additional risk for\nwhom surgery alone may not be a curative treatment. During the past two decades,\nmany clinicopathologic studies indicate the importance of tumor angiogenic activity\nin defining the aggressiveness of tumor behavior [<xref ref-type=\"bibr\" rid=\"CR15\">\n15</xref>]. The microvessel density (MVD), which is based on the morphological\nvisualization and quantification of blood vessels, represents a possible prognostic\nvalue in colorectal cancer [<xref ref-type=\"bibr\" rid=\"CR16\">16</xref>]. Over the\npast decade, numerous studies have investigated the value of angiogenesis markers in\nCRC. Endoglin is a proliferation-associated antigen on endothelial cells and\nessential for angiogenesis. It has been reported that expression of the endoglin in\ntumor endothelium may be a prognostic indicator of the outcome for various human\ntumors including and colorectal cancer (CRC) [<xref ref-type=\"bibr\" rid=\"CR17\">17</xref>].\nMany angiogenesis markers have been studied but have not been used in conjunction\nwith the angiogenesis in the surgical resection margins.</p>\n",
                            "<p>Microvessel density assessment is the most commonly used technique to quantify\nintra-tumoral angiogenesis in cancer. In the present study, we assessed MVD with\nCD105 marker in RC tissue, distal resection margin, and proximal resection margin.\nIn our cohort, endoglin microvessel immunostaining was consistently present in all\nthe cases studied. We showed that the CD105-MVD values significantly increase in RC\nfrom the proximal and distal resection margin to the primary tumor (Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). These results support the role of CD105 as\nan optimal marker of proliferation of endothelial cells and its potential as\nprognostic factor [<xref ref-type=\"bibr\" rid=\"CR13\">13</xref>, <xref ref-type=\"bibr\" rid=\"CR14\">14</xref>, <xref ref-type=\"bibr\" rid=\"CR18\">18</xref>]. In our study,\noverall 5-year recurrence rate for all patients included in this study was\n16.8\u00a0%.</p>\n"
                        ]
                    },
                    {
                        "content": "46.1",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in PRM",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.0211",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "\u226427.8",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "22",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">MVD were analyzed in tumors, distal resection margins, and proximal resection\nmargins. Examples of CD105 expression in the tumor samples, distal resection\nmargins, and the proximal resection margins are shown in Fig.\u00a0<xref rid=\"Fig1\" ref-type=\"fig\">1</xref>. Median CD105-assessed MVD in tumors was\n174.47 vessels/mm<sup>2</sup> (95 % CI 151.00\u2013205.29), distal resection\nmargins 89.86 vessels/mm<sup>2</sup> (95 % CI 55.46\u2013103.80), and the\nproximal resection margins 58.82 vessels/mm<sup>2</sup> (95 % CI\n51.42\u201382.56). The MVD was significantly higher in the tumor samples\ncompared with distal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (Wilcoxon test, <italic>p</italic>\u2009&lt;\u20090.0001)\n(Fig.\u00a0<xref rid=\"Fig2\" ref-type=\"fig\">2</xref>). There was no\nsignificant difference in the MVD between distal and proximal resection margins\n(Wilcoxon test, <italic>p</italic>\u2009=\u20090.147). We found that\nCD105-MVD in tumor tissue (rho\u2009=\u2009\u22120.321, <italic>p</italic>\u2009=\u20090.0015,\n95 % CI \u2212.491 to \u22121.128) and proximal resection margins\n(rho\u2009=\u2009\u22120.220, <italic>p</italic>\u2009=\u20090.0324,\n95 % CI \u22120.403 to \u22120.019) correlated inversely with tumor\nrecurrence rate. On the other hand, CD105-MVD in distal resection margins\n(rho\u2009=\u20090.312, <italic>p</italic>\u2009=\u20090.0021, 95 %\nCI 0.118 to 0.483) correlated positively with tumor recurrence rate. There was\nstatistically significant correlation between CD105-MVD in tumor (\u2264106.2\nvessels/mm<sup>2</sup>/&gt;106.2 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3a</xref>; <italic>p</italic>\u2009=\u20090.0037),\nCD105-MVD in DRM (\u2264186.3 vessels/mm<sup>2</sup>/&gt;186.3\nvessels/mm<sup>2</sup> (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3b</xref>; <italic>\np</italic>\u2009=\u20090.0076), CD105-MVD in PRM (\u226427.8 vessels/mm<sup>\n2</sup>/&gt;27.8 vessels/mm<sup>2</sup>) (Fig.\u00a0<xref rid=\"Fig3\" ref-type=\"fig\">3c</xref>; <italic>p</italic>\u2009=\u20090.0490), and\ntumor recurrence as determined by Fisher\u2019s exact test.<fig id=\"Fig1\">\n<label>Fig. 1</label>\n<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig1_HTML\" id=\"MO1\" />\n</fig><fig id=\"Fig2\">\n<label>Fig. 2</label>\n<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig2_HTML\" id=\"MO2\" />\n</fig><fig id=\"Fig3\">\n<label>Fig. 3</label>\n<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig3_HTML\" id=\"MO3\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>Recurrence rates in our cohort stage II RC patients were analyzed according to age,\ngender, surgery, tumor location, grade of differentiation, histology, depth of tumor\ninvasion, and tumor size (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>).\nBy univariate analysis, only the type of surgical resection was found to be\nsignificant prognostic factors for tumor recurrence. Patients treated with a primary\nAPR had a higher rate of tumor recurrence than those who underwent a LAR, which is\nin accordance with the results of most of the authors [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>]. Previous studies have demonstrated an LAR to APR ratio\n3:1 or 4:1 which is consistent with our results [<xref ref-type=\"bibr\" rid=\"CR19\">19</xref>\n, <xref ref-type=\"bibr\" rid=\"CR20\">20</xref>]. However, most studies were too small\nto adequately evaluate the relationship between the type surgery and tumor\nrecurrence (TR). The key to successful surgery is complete excision of the tumor\nwith sufficient margin of normal tissue. TR may also sometimes occur even in the\nabsence of an involved CRM possibly owing to lymphatic spread from the distal rectum\nto lymph nodes in the pelvic side wall [<xref ref-type=\"bibr\" rid=\"CR21\">21</xref>].\nIn low rectal cancer, total mesorectal excision (TME) surgery may be insufficient to\nobtain the desired CRM because of lack of mesorectum at the level of the pelvic\nfloor [<xref ref-type=\"bibr\" rid=\"CR22\">22</xref>]. APR surgery frequently results\nin perineal and presacral TR [<xref ref-type=\"bibr\" rid=\"CR23\">23</xref>]. The\nchoice of surgical resection is limited and influenced by tumor staging, tumor\nlocation, and intrapelvic tumor invasion at the time of the diagnosis [<xref ref-type=\"bibr\" rid=\"CR24\">24</xref>].</p>\n",
                            "<p>For colorectal cancer, conflicting results have been reported on the prognostic\nimportance of MVD in prediction of tumor aggressive behavior in various subsets of\npatients. Due to inconsistent methods of analysis of tumor angiogenesis in various\nstudies, it is difficult to compare the values of MVD obtained in our analysis with\nthe results of other authors. In our analysis, we found higher values of MVD\n(CD105-MVD, 221.0/mm<sup>2</sup> on average) in RC tissues in comparison with the\nresults in the study of Svagzdys et al. (CD34-MVD, 193.0/mm<sup>2</sup> on average),\npossibly due to the larger surface of the analyzed tumor tissue (0.612 versus\n0.576/mm<sup>2</sup>) and the use of different endothelial cell markers [<xref ref-type=\"bibr\" rid=\"CR26\">26</xref>]. In the present study, the microvessel\ncounts are high and confirm that the rectal carcinoma is strongly dependent on\nangiogenesis.</p>\n"
                        ]
                    },
                    {
                        "content": "31.8",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": ">27.8",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The cut-off value for determining high and low MVD with respect to recurrent\ntumor was performed by the receiver operating characteristic (ROC) curve\nanalysis. The cut-off value for MVD in tumors, distal and proximal resection\nmargins were \u2264106.2 microvessel/mm<sup>2</sup> (sensitivity\n56.2\u00a0%, specificity 81.0\u00a0%), &gt;186.3 microvessel/mm<sup>2</sup>\n(sensitivity 37.5\u00a0%, specificity 91.1\u00a0%), and \u226427.8\n(sensitivity 43.7\u00a0%, specificity 81.0\u00a0%), respectively\n(Table\u00a0<xref rid=\"Tab3\" ref-type=\"table\">3</xref>). The cut-off values\nfor MVD in the primary tumors, distal resection margins, and proximal resection\nmargins are shown in Fig.\u00a0<xref rid=\"Fig5\" ref-type=\"fig\">5</xref>.<table-wrap id=\"Tab3\">\n<label>Table 3</label>\n<caption>\n<p>Optimal cut-off point of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>AUC</th>\n<th>Cut-off value</th>\n<th>Sensitivity</th>\n<th>Specificity</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td char=\".\" align=\"char\">0.601</td>\n<td char=\".\" align=\"char\">106.2</td>\n<td char=\".\" align=\"char\">56.2</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td char=\".\" align=\"char\">0.656</td>\n<td char=\".\" align=\"char\">186.3</td>\n<td char=\".\" align=\"char\">37.5</td>\n<td char=\".\" align=\"char\">91.1</td>\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td char=\".\" align=\"char\">0.602</td>\n<td char=\".\" align=\"char\">27.8</td>\n<td char=\".\" align=\"char\">43.7</td>\n<td char=\".\" align=\"char\">81.0</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>AUC</italic> area under the curve</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig5\">\n<label>Fig. 5</label>\n<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig5_HTML\" id=\"MO5\" />\n</fig></p>\n"
                        ]
                    },
                    {
                        "content": "73",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">The Kaplan-Meier method and log-rank test were performed. In the univariate\nanalysis (Table\u00a0<xref rid=\"Tab2\" ref-type=\"table\">2</xref>), the type of\nsurgical resection was a significant factor for determining the recurrence of\ntumors (log-rank test, <italic>p</italic>\u2009=\u20090.0104)\n(Fig.\u00a0<xref rid=\"Fig4\" ref-type=\"fig\">4</xref>). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade of\ndifferentiation, histological tumor type, the size and depth of tumor invasion\non the recurrence of the tumor.<table-wrap id=\"Tab2\">\n<label>Table 2</label>\n<caption>\n<p>Univariate analysis for tumor recurrence</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variable</th>\n<th>Hazard ratio</th>\n<th>95\u00a0% CI</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Age (median)</td>\n<td />\n<td />\n<td>0.716</td>\n</tr>\n<tr>\n<td>\u2003\u226469</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;69</td>\n<td>0.839</td>\n<td>0.310\u20132.268</td>\n<td />\n</tr>\n<tr>\n<td>Gender</td>\n<td />\n<td />\n<td>0.142</td>\n</tr>\n<tr>\n<td>\u2003Male</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Female</td>\n<td>0.426</td>\n<td>0.152\u20131.190</td>\n<td />\n</tr>\n<tr>\n<td>Type of surgery</td>\n<td />\n<td />\n<td>0.010</td>\n</tr>\n<tr>\n<td>\u2003Low anterior resection</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Abdominoperineal resection</td>\n<td>3.140</td>\n<td>0.919\u201310.725</td>\n<td />\n</tr>\n<tr>\n<td>Tumor location</td>\n<td />\n<td />\n<td>0.710</td>\n</tr>\n<tr>\n<td>\u2003Upper rectum</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Middle rectum</td>\n<td>1.267</td>\n<td>0.381\u20134.213</td>\n<td />\n</tr>\n<tr>\n<td>\u2003Low rectum</td>\n<td>1.716</td>\n<td>0.419\u20137.026</td>\n<td />\n</tr>\n<tr>\n<td>Grade of differentiation</td>\n<td />\n<td />\n<td>0.936</td>\n</tr>\n<tr>\n<td>\u2003G1</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003G2</td>\n<td>1.933</td>\n<td>0.416\u20133.423</td>\n<td />\n</tr>\n<tr>\n<td>\u2003G3</td>\n<td>1.119</td>\n<td>0.137\u20139.137</td>\n<td />\n</tr>\n<tr>\n<td>Histologic type</td>\n<td />\n<td />\n<td>0.299</td>\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003Adenocarcinoma with mucinous features</td>\n<td>0.381</td>\n<td>0.096\u20131.514</td>\n<td />\n</tr>\n<tr>\n<td>Depth of tumor invasion</td>\n<td />\n<td />\n<td>0.925</td>\n</tr>\n<tr>\n<td>\u2003T3</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003T4a</td>\n<td>0.919</td>\n<td>0.316\u20132.673</td>\n<td />\n</tr>\n<tr>\n<td>\u2003T4b</td>\n<td>0.745</td>\n<td>0.172\u20133.223</td>\n<td />\n</tr>\n<tr>\n<td>Tumor size</td>\n<td />\n<td />\n<td>0.329</td>\n</tr>\n<tr>\n<td>\u2003\u22644\u00a0cm</td>\n<td>1.000</td>\n<td />\n<td />\n</tr>\n<tr>\n<td>\u2003&gt;4\u00a0cm</td>\n<td>0.594</td>\n<td>0.214\u20131.651</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>\n<italic>95\u00a0% CI</italic> confidence interval</p>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig4\">\n<label>Fig. 4</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig4_HTML\" id=\"MO4\" />\n</fig></p>\n",
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "12.3",
                        "cited_in": [
                            "<p xmlns:ns0=\"http://www.w3.org/1999/xlink\">In a Kaplan-Meier recurrence of tumors estimate (Table\u00a0<xref rid=\"Tab4\" ref-type=\"table\">4</xref>), tumor with a low MVD (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6a</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0008)\nand tumor with low MVD proximal resection margin (Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6b</xref>, log-rank test, <italic>p</italic>\u2009=\u20090.0074)\nhad significantly higher risk of developing recurrence. The risk of developing\nrecurrence was significantly higher in the group of patients with high MVD\ndistal resection margin compared with low MVD distal resection margin\n(Fig.\u00a0<xref rid=\"Fig6\" ref-type=\"fig\">6c</xref>, log-rank test, <italic>\np</italic>\u2009=\u20090.0211).<table-wrap id=\"Tab4\">\n<label>Table 4</label>\n<caption>\n<p>The recurrence rates and univariate analysis according to cut-off\nvalues for MVD</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Variables</th>\n<th>Cut-off value</th>\n<th>Number of patients</th>\n<th>Recurrence rates</th>\n<th>\n<italic>p</italic> value*</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>MVD in tumors</td>\n<td />\n<td />\n<td />\n<td>0.0008</td>\n</tr>\n<tr>\n<td />\n<td>\u2264106.2</td>\n<td>24</td>\n<td>37.5</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;106.2</td>\n<td>71</td>\n<td>9.8</td>\n<td />\n</tr>\n<tr>\n<td>MVD in DRM</td>\n<td />\n<td />\n<td />\n<td>0.0074</td>\n</tr>\n<tr>\n<td />\n<td>\u2264186.3</td>\n<td>82</td>\n<td>12.2</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;186.3</td>\n<td>13</td>\n<td>46.1</td>\n<td />\n</tr>\n<tr>\n<td>MVD in PRM</td>\n<td />\n<td />\n<td />\n<td>0.0211</td>\n</tr>\n<tr>\n<td />\n<td>\u226427.8</td>\n<td>22</td>\n<td>31.8</td>\n<td />\n</tr>\n<tr>\n<td />\n<td>&gt;27.8</td>\n<td>73</td>\n<td>12.3</td>\n<td />\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>*log-rank test</p>\n</table-wrap-foot>\n</table-wrap><fig id=\"Fig6\">\n<label>Fig. 6</label>\n<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n<graphic ns0:href=\"12957_2016_877_Fig6_HTML\" id=\"MO6\" />\n</fig></p>\n"
                        ]
                    }
                ]
            },
            {
                "table_id": "Tab5",
                "body": "<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n",
                "caption": "<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n",
                "foots": [
                    "<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n",
                    "<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n"
                ],
                "paragraphs": [
                    {
                        "text": "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n",
                        "citations": []
                    }
                ],
                "cells": [
                    {
                        "content": "Type of surgery (LAR versus APR)",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.0086",
                        "cited_in": [
                            "<p>The MVD was significantly higher in the tumor samples compared with the\ndistal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001).\nThere was no significant difference in the MVD between distal and proximal\nresection margins (<italic>p</italic>\u2009=\u20090.147). The type of\nsurgical resection was a significant factor for determining the recurrence\nof tumors (<italic>p</italic>\u2009=\u20090.0104). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade\nof differentiation, histological tumor type, and the size and depth of tumor\ninvasion on the recurrence of the tumor. The recurrence rate was\nsignificantly higher in the low CD105-MVD group of patients than in the high\nCD105-MVD group of patients (log rank test, <italic>p</italic>\u2009=\u20090.0406).\nResult of the multivariate analysis showed that the type of surgery (<italic>\np</italic>\u2009=\u20090.0086), MVD tumors (<italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (<italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for the recurrent tumors.</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "4.1103",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "1.4397\u201311.7346",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "Tumor size (\u22644 versus >4\u00a0cm)",
                        "cited_in": []
                    },
                    {
                        "content": "0.0577",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.3356",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.1093\u20131.0302",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in tumors (\u2264106.2 versus >106.2)",
                        "cited_in": []
                    },
                    {
                        "content": "0.0385",
                        "cited_in": [
                            "<p>The MVD was significantly higher in the tumor samples compared with the\ndistal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001).\nThere was no significant difference in the MVD between distal and proximal\nresection margins (<italic>p</italic>\u2009=\u20090.147). The type of\nsurgical resection was a significant factor for determining the recurrence\nof tumors (<italic>p</italic>\u2009=\u20090.0104). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade\nof differentiation, histological tumor type, and the size and depth of tumor\ninvasion on the recurrence of the tumor. The recurrence rate was\nsignificantly higher in the low CD105-MVD group of patients than in the high\nCD105-MVD group of patients (log rank test, <italic>p</italic>\u2009=\u20090.0406).\nResult of the multivariate analysis showed that the type of surgery (<italic>\np</italic>\u2009=\u20090.0086), MVD tumors (<italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (<italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for the recurrent tumors.</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.3330",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.1182\u20130.9384",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in DRM (\u2264186.3 versus >186.3)",
                        "cited_in": []
                    },
                    {
                        "content": "0.0537",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "2.9359",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.9885\u20138.7195",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "MVD in PRM (\u226427.8 versus >27.8)",
                        "cited_in": []
                    },
                    {
                        "content": "0.0218",
                        "cited_in": [
                            "<p>The MVD was significantly higher in the tumor samples compared with the\ndistal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001)\nand the proximal resection margins (<italic>p</italic>\u2009&lt;\u20090.0001).\nThere was no significant difference in the MVD between distal and proximal\nresection margins (<italic>p</italic>\u2009=\u20090.147). The type of\nsurgical resection was a significant factor for determining the recurrence\nof tumors (<italic>p</italic>\u2009=\u20090.0104). There was no\nsignificant effect of patients\u2019 age, gender, tumor location, grade\nof differentiation, histological tumor type, and the size and depth of tumor\ninvasion on the recurrence of the tumor. The recurrence rate was\nsignificantly higher in the low CD105-MVD group of patients than in the high\nCD105-MVD group of patients (log rank test, <italic>p</italic>\u2009=\u20090.0406).\nResult of the multivariate analysis showed that the type of surgery (<italic>\np</italic>\u2009=\u20090.0086), MVD tumors (<italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (<italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for the recurrent tumors.</p>\n",
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.2778",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    },
                    {
                        "content": "0.0935\u20130.8255",
                        "cited_in": [
                            "<p>The prognostic variables were determined by Cox proportional hazard regression\nanalysis. The variables: age, gender, type of surgical resection, tumor\nlocation, grade of differentiation, histological type, depth of tumor invasion,\ntumor size, length of the surgical distal and proximal margin, MVD tumors, and\nMVD of surgical distal and proximal margin were entered into the multivariate\nmodel to determine their relation with recurrent tumors.\n\u201cBackward\u201d analysis was performed. Results of the multivariate\nanalysis are presented in Table\u00a0<xref rid=\"Tab5\" ref-type=\"table\">5</xref>.\nThe result showed that the type surgery (OR\u2009=\u20094.11, <italic>p</italic>\u2009=\u20090.0086),\nMVD tumors (OR\u2009=\u20090.33, <italic>p</italic>\u2009=\u20090.0385),\nand MVD of proximal resection margin (OR\u2009=\u20090.27, <italic>p</italic>\u2009=\u20090.0218)\nwere the independent prognostic factors for recurrent tumors. Tumor size and MVD\ndistal resection margins were on the border of significance.<table-wrap id=\"Tab5\">\n<label>Table 5</label>\n<caption>\n<p>Cox proportional-hazard regression analysis for tumor recurrence\n(method \u201cbackward\u201d)</p>\n</caption>\n<table frame=\"hsides\" rules=\"groups\">\n<thead>\n<tr>\n<th>Covariate</th>\n<th>\n<italic>p</italic> value</th>\n<th>OR</th>\n<th>(95 % CI)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Type of surgery (LAR versus APR)</td>\n<td char=\".\" align=\"char\">0.0086</td>\n<td>4.1103</td>\n<td>1.4397\u201311.7346</td>\n</tr>\n<tr>\n<td>Tumor size (\u22644 versus &gt;4\u00a0cm)</td>\n<td char=\".\" align=\"char\">0.0577</td>\n<td>0.3356</td>\n<td>0.1093\u20131.0302</td>\n</tr>\n<tr>\n<td>MVD in tumors (\u2264106.2 versus &gt;106.2)</td>\n<td>0.0385</td>\n<td char=\".\" align=\"char\">0.3330</td>\n<td>0.1182\u20130.9384</td>\n</tr>\n<tr>\n<td>MVD in DRM (\u2264186.3 versus &gt;186.3)</td>\n<td char=\".\" align=\"char\">0.0537</td>\n<td>2.9359</td>\n<td>0.9885\u20138.7195</td>\n</tr>\n<tr>\n<td>MVD in PRM (\u226427.8 versus &gt;27.8)</td>\n<td char=\".\" align=\"char\">0.0218</td>\n<td>0.2778</td>\n<td>0.0935\u20130.8255</td>\n</tr>\n</tbody>\n</table>\n<table-wrap-foot>\n<p>Overall model fit <italic>\u03c7</italic>\n<sup>2</sup>\n\u2009=\u200923.20, <italic>p</italic>\u2009=\u20090.0003</p>\n<p>\n<italic>MVD</italic> microvessel density, <italic>OR</italic> odds\nratio, <italic>95 % CI</italic> confidence interval, <italic>DRM</italic> distal\nresection margin, <italic>PRM</italic> proximal resection margin</p>\n</table-wrap-foot>\n</table-wrap></p>\n"
                        ]
                    }
                ]
            }
        ],
        "figures": [
            {
                "fig_id": "Fig1",
                "caption": "<caption>\n<p>Immunohistochemical staining for the CD105 endothelial antigen in the\ntumor samples (<bold>a</bold>), distal resection margins (<bold>b</bold>), and\nthe proximal resection margins (<bold>c</bold>). Magnification \u00d7200</p>\n</caption>\n",
                "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840965/bin/12957_2016_877_Fig1_HTML.jpg"
            },
            {
                "fig_id": "Fig2",
                "caption": "<caption>\n<p>Box-and-whisker plots of CD105-MVD in tumors, distal resection\nmargins, and proximal resection margins. The CD105-MVD level was significantly\nhigher in the tumor compared with the distal resection margin (<italic>p</italic>\u2009&lt;\u20090.001)\nand the proximal resection margin (<italic>p</italic>\u2009&lt;\u20090.001).\nIn these box plots, median values are represented by <italic>lines within the\nboxes</italic>, <italic>whiskers</italic> represent the interquartile range, and\noutliers are represented as individual data points</p>\n</caption>\n",
                "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840965/bin/12957_2016_877_Fig2_HTML.jpg"
            },
            {
                "fig_id": "Fig3",
                "caption": "<caption>\n<p>Correlation analysis between tumor recurrence and CD105-MVD in tumor,\ndistal and proximal resection margin. <bold>a</bold> Recurrence and CD105-MVD in\ntumor (<italic>p</italic>\u2009=\u20090.0037). <bold>b</bold> Recurrence\nand CD105-MVD in DRM (<italic>p</italic>\u2009=\u20090.0076). <bold>c</bold>\nRecurrence and CD105-MVD in PRM (<italic>p</italic>\u2009=\u20090.0490)</p>\n</caption>\n",
                "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840965/bin/12957_2016_877_Fig3_HTML.jpg"
            },
            {
                "fig_id": "Fig4",
                "caption": "<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to the\ntype of surgery. <italic>Solid line</italic>, patients with LAR. <italic>Dotted\nline</italic>, patients with APR</p>\n</caption>\n",
                "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840965/bin/12957_2016_877_Fig4_HTML.jpg"
            },
            {
                "fig_id": "Fig5",
                "caption": "<caption>\n<p>Receiver operating characteristic (ROC) curve analysis for optimal\ncut-off point of CD105-MVD. <bold>a</bold> Cut-off value of MVD in tumor\n106.2/mm<sup>2</sup>. <bold>b</bold> Cut-off value of MVD in DRM 186.3/mm<sup>2</sup>\n. <bold>c</bold> Cut-off value of MVD in PRM 27.8/mm<sup>2</sup>\n</p>\n</caption>\n",
                "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840965/bin/12957_2016_877_Fig5_HTML.jpg"
            },
            {
                "fig_id": "Fig6",
                "caption": "<caption>\n<p>Kaplan-Meier curves for recurrence-free survival according to\nCD105-MVD. <bold>a</bold> CD105-MVD in tumor (cut-off level of MVD 106.2/mm<sup>\n2</sup>). <bold>b</bold> CD105-MVD in DRM (cut-off level of MVD 186.3\u00a0mm<sup>\n2</sup>). <bold>c</bold> CD105-MVD in PRM (cut-off level MVD 27.8/mm<sup>2</sup>\n</p>\n</caption>\n",
                "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840965/bin/12957_2016_877_Fig6_HTML.jpg"
            }
        ]
    }
}